Great Valley Advisor Group, Inc. Vertex Pharmaceuticals Inc Transaction History
Great Valley Advisor Group, Inc.
- $4.13 Billion
- Q1 2025
A detailed history of Great Valley Advisor Group, Inc. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Great Valley Advisor Group, Inc. holds 11,583 shares of VRTX stock, worth $4.49 Million. This represents 0.14% of its overall portfolio holdings.
Number of Shares
11,583
Previous 20,593
43.75%
Holding current value
$4.49 Million
Previous $8.29 Million
32.28%
% of portfolio
0.14%
Previous 0.2%
Shares
12 transactions
Others Institutions Holding VRTX
# of Institutions
1,810Shares Held
232MCall Options Held
1.51MPut Options Held
1.08M-
Capital World Investors Los Angeles, CA28.5MShares$11.1 Billion2.34% of portfolio
-
Vanguard Group Inc Valley Forge, PA24MShares$9.3 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$8.26 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA14.5MShares$5.64 Billion1.6% of portfolio
-
State Street Corp Boston, MA11.8MShares$4.57 Billion0.24% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $99.5B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...